Indication
Paronychia
2 clinical trials
2 products
Clinical trial
A Randomized, Placebo-controlled, Parallel Phase 2a Dose-ranging Study to Investigate the Efficacy, Safety, and Tolerability of Topical HT-001 for the Treatment of Skin Toxicities Associated With Epidermal Growth Factor Receptor InhibitorsStatus: Recruiting, Estimated PCD: 2024-12-30
Product
HT-001Clinical trial
The Efficacy of Topical Timolol Combined With Cryotherapy in EGFR Inhibitor-induced Paronychia - a Double-blinded, Intrapatient Left-to-right Controlled StudyStatus: Completed, Estimated PCD: 2023-01-21
Product
Timolol maleate